Boston Trust Walden Corp Axcelis Technologies Inc Transaction History
Boston Trust Walden Corp
- $14 Billion
- Q4 2024
A detailed history of Boston Trust Walden Corp transactions in Axcelis Technologies Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 820,116 shares of ACLS stock, worth $55.8 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
820,116
Previous 506,427
61.94%
Holding current value
$55.8 Million
Previous $53.1 Million
7.93%
% of portfolio
0.41%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding ACLS
# of Institutions
387Shares Held
31.4MCall Options Held
235KPut Options Held
462K-
Black Rock Inc. New York, NY5.81MShares$395 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.29MShares$292 Million0.01% of portfolio
-
State Street Corp Boston, MA1.23MShares$83.9 Million0.01% of portfolio
-
Reinhart Partners, Inc.1.04MShares$70.5 Million2.88% of portfolio
-
Primecap Management CO Pasadena, CA974KShares$66.3 Million0.08% of portfolio
About AXCELIS TECHNOLOGIES INC
- Ticker ACLS
- Exchange NASDAQ
- Sector Technology
- Industry Semiconductor Equipment & Materials
- Shares Outstandng 33,033,800
- Market Cap $2.25B
- Description
- Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecy...